Hyperglycaemia upon onset of ICU-acquired bloodstream infection is associated with adverse outcome in a mixed ICU population

Anaesthesia and Intensive Care

Volumn 36, Issue 1, 2008, Pages 25-29

  Vandijck, D M ^a,b   Oeyen, S G ^a,c   Buyle, F M ^a,d   Claus, B O ^a,d   Blot, S I ^a,e   Decruyenaere, J M ^a,c  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c Department of Intensive Care Medicine ^*

^d Pharmacy Department

^e UNIVERSITY COLLEGE GHENT   (Belgium)

Author keywords

Diabetes; Hospital mortality; Hyperglycaemia; Intensive care unit; Nosocomial bloodstream infection

Indexed keywords

ANTIINFECTIVE AGENT; INSULIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL INFECTION; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; SEPSIS;

EID: 38949134780     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0803600105     Document Type: Article

References (23)

1. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of inhospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87:978-982.
2. Robinson LE, van Soeren MH. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. AACN Clin Issues 2004; 15:45-62.
3. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367.
4. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-873.
5. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20:1183-1197.
6. Van den Berghe G. First do no harm ... Hypoglycemia or hyperglycemia? Crit Care Med 2006; 34:2843-2844.
7. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16:128-140.
8. Blot S, De Bacquer D, Hoste E, Depuydt P, Vandewoude K, De Waele J et al. Influence of matching for exposure time on estimates of attributable mortality caused by nosocomial bacteremia in critically ill patients. Infect Control Hosp Epidemiol 2005; 26:352-356.
9. Vandijck DM, Hoste EA, Blot SI, Depuydt PO, Peleman RA, Decruyenaere JM. Dynamics of C-reactive protein and white blood cell count in critically ill patients with nosocomial Gram-positive vs. Gram-negative bacteremia: A historical cohort study. BMC Infect Dis 2007; 7:106.
10. Hoste EA, Vandijck DM, Van Holder RC, De Waele JJ, Lameire NH, Claus S et al. Health implications of antimicrobial-resistance in bloodstream infection patients with acute kidney injury. Infect Control Hosp Epidemiol 2007; 28:1107-1110.
11. Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract 2004; 10:46-52.
12. Oeyen SG, Hoste EA, Roossens CD, Decruyenaere JM, Blot SI. Adherence to and efficacy and safety of an insulin protocol in the critically ill: a prospective observational study. Am J Crit Care 2007; 16:599-608.
13. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 2001; 15:533-551.
14. Vandijck DM, Decruyenaere JM, Blot SI. The value of sepsis definitions in daily ICU-practice. Acta Clin Belg 2006; 61:220-226.
15. Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001; 51:540-544.
16. Spelman DW, Russo P, Harrington G, Davis BB, Rabinov M, Smith JA et al. Risk factors for surgical wound infection and bacteraemia following coronary artery bypass surgery. Aust N Z J Surg 2000; 70:47-51.
17. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67:352-360.
18. Lang CH, Dobrescu C, Bagby GJ. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 1992; 130:43-52.
19. Corstjens AM, van der Horst IC, Zijlstra JG, Groeneveld AB, Zijlstra F, Tulleken JE et al. Hyperglycaemia in critically ill patients: marker or mediator of mortality? Crit Care 2006; 10:216.
20. Andersen SK, Gjedsted J, Christiansen C, Tonnesen E. The roles of insulin and hyperglycemia in sepsis pathogenesis. J Leukoc Biol 2004; 75:413-421.
21. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003; 88:1082-1088.
22. Ellger B, Debaveye Y, Vanhorebeek I, Langouche L, Giulietti A, Van Etten E et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 2006; 55:1096-1105.
23. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31:359-366.